GoodRx Holdings Inc. Class A (NASDAQ:GDRX)
Market Cap | 475.78M |
---|---|
Revenue | 795.70M |
Gross Profit | 734.06M |
Shares Out | 82.46M |
EPS (ttm) | -0.1744 |
PE Ratio | -6.7229 |
Forward PE | 21.5802 |
Dividend Rate (ttm) | 0.0000 |
Dividend Yield | 0.0000 |
Trading Day | Feb 3 |
---|---|
Last Price | $5.77 |
Previous Close | $6.12 |
Change ($) | -0.35 |
Change (%) | -5.72% |
Day's Open | 5.97 |
Day's Range | 5.7 - 6.11 |
Day's Volume | 1.25M |
52 Week Range | 3.82 - 30.89 |
About GoodRx Holdings Inc. Class A
GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions.
The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, HeyDoctor and the GoodRx Telehealth Marketplace, and other healthcare related content.
Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee.
Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.
News
Quick info
GoodRx Holdings Inc. Class A income statements (2022) (USD)
August 2022 | August 2022 | May 2022 | May 2022 | March 2022 | |
---|---|---|---|---|---|
Total Revenue | 191.80M | 191.80M | 203.33M | 203.33M | 213.26M |
Cost of Revenue | 18.04M | 18.04M | 12.28M | 12.28M | 13.93M |
Gross Profit | 173.75M | 173.75M | 191.05M | 191.05M | 199.33M |
Research & Development | 35.40M | 35.40M | 35.04M | 35.04M | 35.06M |
Selling General & Admin | 129.08M | 129.08M | 124.87M | 124.87M | 141.87M |
Operating Expense | 195.85M | 195.85M | 183.57M | 183.57M | 201.50M |
Operating Income | -4.05M | -4.05M | 19.76M | 19.76M | 11.76M |
Other Income Expense Net | 0 | 0 | 0 | 0 | 0 |
EBIT | -4.05M | -4.05M | 19.76M | 19.76M | 11.76M |
Interest Income | 6.11M | 6.11M | 5.82M | 5.82M | 5.89M |
Pretax Income | -10.16M | -10.16M | 13.94M | 13.94M | 5.87M |
Income Tax | -8.74M | -8.74M | 1.65M | 1.65M | 45.78M |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Net Income | -1.42M | -1.42M | 12.29M | 12.29M | -39.91M |
Net Income Basic | -1.42M | -1.42M | 12.29M | 12.29M | -39.91M |
GoodRx Holdings Inc. Class A income statements (2021) (USD)
November 2021 | August 2021 | August 2021 | May 2021 | May 2021 | March 2021 | |
---|---|---|---|---|---|---|
Total Revenue | 195.10M | 176.64M | 176.64M | 160.43M | 160.43M | 550.70M |
Cost of Revenue | 11.27M | 11.09M | 11.09M | 10.43M | 10.43M | 29.59M |
Gross Profit | 183.83M | 165.55M | 165.55M | 150M | 150M | 521.11M |
Research & Development | 35.07M | 29.57M | 29.57M | 26.16M | 26.16M | 61.82M |
Selling General & Admin | 131.60M | 127.96M | 127.96M | 123.48M | 123.48M | 716.59M |
Operating Expense | 188.10M | 176.99M | 176.99M | 165.43M | 165.43M | 826.42M |
Operating Income | 7M | -351K | -351K | -5M | -5M | -275.72M |
Other Income Expense Net | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 7M | -351K | -351K | -5M | -5M | -275.72M |
Interest Income | 5.92M | 5.89M | 5.89M | 5.89M | 5.89M | 27.75M |
Pretax Income | 1.08M | -6.24M | -6.24M | -10.89M | -10.89M | -303.45M |
Income Tax | 19.15M | -37.31M | -37.31M | -12.56M | -12.56M | -9.83M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income | -18.07M | 31.06M | 31.06M | 1.67M | 1.67M | -293.62M |
Net Income Basic | -18.07M | 31.06M | 31.06M | 1.67M | 1.67M | -293.62M |
GoodRx Holdings Inc. Class A balance sheet (2022) (USD)
August 2022 | August 2022 | May 2022 | May 2022 | March 2022 | |
---|---|---|---|---|---|
Current Cash | 730.54M | 730.54M | 845.43M | 845.43M | 0.94B |
Receivables | 122.88M | 122.88M | 123.28M | 123.28M | 118.08M |
Inventory | 0 | 0 | 0 | 0 | 0 |
Current Assets | 893.96M | 893.96M | 0.99B | 0.99B | 1.09B |
Other Current Assets | 40.54M | 40.54M | 26.02M | 26.02M | 29.64M |
Short Term Investments | 40.54M | 40.54M | 26.02M | 26.02M | 29.64M |
Long Term Investments | 698.04M | 698.04M | 543.61M | 543.61M | 518.80M |
Property/Plant Equipment | 22.88M | 22.88M | 22.56M | 22.56M | 21.61M |
Good Will | N.A | N.A | N.A | N.A | N.A |
Intangible Assets | 193.42M | 193.42M | 138.50M | 138.50M | 133.78M |
Tangible Assets (Net) | 209.27M | 209.27M | 313.37M | 313.37M | 368.21M |
Other Assets | 37.98M | 37.98M | 20.93M | 20.93M | 6.01M |
Total Assets | 1.59B | 1.59B | 1.54B | 1.54B | 1.61B |
Accounts Payable | 16.83M | 16.83M | 12.82M | 12.82M | 17.50M |
Other Current Liabilities | 55.76M | 55.76M | 39.52M | 39.52M | 56.58M |
Total Current Liabilities | 79.62M | 79.62M | 59.36M | 59.36M | 81.11M |
Total Liabilities | 774.06M | 774.06M | 751.82M | 751.82M | 775.95M |
Long Term Debt | 653.83M | 653.83M | 654.85M | 654.85M | 655.86M |
Current Long Term Debt | 7.03M | 7.03M | 7.03M | 7.03M | 7.03M |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Common Stock | 412.14M | 412.14M | 414.74M | 414.74M | 414.17M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -1.4B | -1.4B | -1.4B | -1.4B | -1.42B |
Capital Surplus | N.A | N.A | N.A | N.A | N.A |
Shareholder Equity | 817.94M | 817.94M | 786.51M | 786.51M | 831.68M |
Other Liabilities | N.A | N.A | N.A | N.A | N.A |
GoodRx Holdings Inc. Class A balance sheet (2021) (USD)
November 2021 | August 2021 | August 2021 | May 2021 | May 2021 | March 2021 | |
---|---|---|---|---|---|---|
Current Cash | 0.91B | 894.70M | 894.70M | 0.99B | 0.99B | 0.97B |
Receivables | 98.51M | 87M | 87M | 74.40M | 74.40M | 68.73M |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 1.05B | 1.08B | 1.08B | 1.12B | 1.12B | 1.09B |
Other Current Assets | 41.01M | 94.04M | 94.04M | 55.62M | 55.62M | 46.05M |
Short Term Investments | 41.01M | 94.04M | 94.04M | 55.62M | 55.62M | 46.05M |
Long Term Investments | 562.83M | 511.18M | 511.18M | 387.59M | 387.59M | 383.75M |
Property/Plant Equipment | 21.84M | 22.11M | 22.11M | 22.69M | 22.69M | 23.06M |
Good Will | N.A | N.A | N.A | N.A | N.A | N.A |
Intangible Assets | 133.33M | 126.78M | 126.78M | 60.39M | 60.39M | 56.72M |
Tangible Assets (Net) | 383.37M | 377.42M | 377.42M | 427.56M | 427.56M | 393.52M |
Other Assets | 6.17M | 2.23M | 2.23M | 2.17M | 2.17M | 2.03M |
Total Assets | 1.61B | 1.59B | 1.59B | 1.51B | 1.51B | 1.47B |
Accounts Payable | 17.28M | 18.38M | 18.38M | 15.10M | 15.10M | 10.29M |
Other Current Liabilities | 48.37M | 40.08M | 40.08M | 40.92M | 40.92M | 42.23M |
Total Current Liabilities | 72.68M | 65.49M | 65.49M | 63.05M | 63.05M | 59.55M |
Total Liabilities | 767.97M | 762.54M | 762.54M | 761.92M | 761.92M | 758.76M |
Long Term Debt | 656.87M | 657.88M | 657.88M | 658.88M | 658.88M | 659.89M |
Current Long Term Debt | 7.03M | 7.03M | 7.03M | 7.03M | 7.03M | 7.03M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock | 411.22M | 408.36M | 408.36M | 406.17M | 406.17M | 274.70M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -1.38B | -1.36B | -1.36B | -1.39B | -1.39B | -1.39B |
Capital Surplus | N.A | N.A | N.A | N.A | N.A | N.A |
Shareholder Equity | 846.40M | 824.39M | 824.39M | 749.06M | 749.06M | 711.36M |
Other Liabilities | N.A | N.A | N.A | N.A | N.A | N.A |
GoodRx Holdings Inc. Class A cash flow (2022) (USD)
August 2022 | May 2022 | March 2022 | |
---|---|---|---|
Net Income | -1.42M | 12.29M | -39.91M |
Depreciation | 13.32M | 11.37M | 10.65M |
Changes in Receivables | 122.88M | 123.28M | 118.08M |
Changes in Inventories | 0 | 0 | 0 |
Cash Change | 730.54M | 845.43M | 0.94B |
Cash Flow | 51.05M | 30.12M | 49.81M |
Capital Expenditures | -13.73M | -12.42M | -9.26M |
Investments | N.A | N.A | N.A |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -163.61M | -34.4M | -9.26M |
Dividends Paid | N.A | N.A | N.A |
Net Borrowings | -110.22M | -209.57M | -307.86M |
Other Financing Cash Flows | N.A | N.A | N.A |
Cash Flow Financing | -2.33M | -91.4M | -11.47M |
Exchange Rate Effect | N.A | N.A | N.A |
GoodRx Holdings Inc. Class A cash flow (2021) (USD)
November 2021 | August 2021 | May 2021 | |
---|---|---|---|
Net Income | -18.07M | 31.06M | 1.67M |
Depreciation | 10.16M | 8.37M | 5.36M |
Changes in Receivables | 98.51M | 87M | 74.40M |
Changes in Inventories | 0 | 0 | 0 |
Cash Change | 0.91B | 894.70M | 0.99B |
Cash Flow | 48.56M | 34.93M | 45.49M |
Capital Expenditures | -8.51M | -6.99M | -9.7M |
Investments | N.A | N.A | N.A |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -27.06M | -132.72M | -9.7M |
Dividends Paid | N.A | N.A | N.A |
Net Borrowings | -289.13M | -323.84M | -380.17M |
Other Financing Cash Flows | N.A | N.A | N.A |
Cash Flow Financing | -4.18M | -865K | -14.02M |
Exchange Rate Effect | N.A | N.A | N.A |
GoodRx Holdings Inc. Class A dividends (USD)
Total Valuation
GoodRx Holdings Inc - Class A has a market cap or net worth of $475.78 million. The enterprise value is $406.84 million.
Important Dates
Share Statistics
GoodRx Holdings Inc - Class A has 82.46 million shares outstanding.
Valuation Ratios
The trailing PE ratio is -6.7229 and the forward PE ratio is 21.5802. GoodRx Holdings Inc - Class A's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.2382%. The beta is 2.1736, so GoodRx Holdings Inc - Class A's price volatility has been higher than the market average.
Income Statement
In the last 12 months, GoodRx Holdings Inc - Class A had revenue of $795.70 million and earned $734.06 million in profits. Earnings per share was $-0.1744.